Mylan Launches Generic Norvasc; 180-Day Exclusivity May Be Moot
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer counters by launching an “authorized” generic under its Greenstone brand.
You may also be interested in...
Prescription Drug Sales Up Just 4 Percent In 2007 – IMS Health Report
Generic competition, safety issues and Medicare Part D are factors in decline to 3.8 percent growth from 8 percent in 2006.
Prescription Drug Sales Up Just 4 Percent In 2007 – IMS Health Report
Generic competition, safety issues and Medicare Part D are factors in decline to 3.8 percent growth from 8 percent in 2006.
UCB Seeks FDA Approval For Cimzia In Rheumatoid Arthritis
The biologic, which has yet to obtain a Crohn’s indication in the U.S. and Europe, is backed by efficacy data from three Phase III trials in RA.